Impact of a Personalized Medication Plan on Duration of Treatment With Potent Opioids in Acute Non-cancer Musculoskeletal Pain. (PPPCARE II)

Inclusion Criteria: Patient hospitalized in the rheumatology department Patient with acute pain in the context of a non-cancerous, non-traumatic, high-energy musculoskeletal pathology Patient for whom a prescription of strong opioid derivatives is initiated in rheumatology or patient for whom a prescription of strong opioid derivatives is maintained in rheumatology if the initial prescription has a maximum duration of 30 consecutive days prior to inclusion Exclusion Criteria: Patient with cancer or fibromyalgia already diagnosed at inclusion Patient with poor French language skills Taking a strong opioid treatment for more than 30 consecutive days prior to inclusion Person judged by the prescriber or pharmacist as not autonomous for the management of strong opioid treatment Patient already included in the study